Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever)

  • Withdrawn
  • Review
  • Intervention

Authors


Reason for withdrawal from publication

2011, Issue 10: Review status: Current question – no update intended. Azithromycin treatments are included in the review: Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). (Thaver D, Zaidi AKM, Critchley JA, Azmatullah A, Madni SA, Bhutta ZA. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD004530. DOI: 10.1002/14651858.CD004530.pub3.)   This latter review is being updated, and will be published in late 2011. The azithrocycin review is therefore withdrawn.

The review status reports aims to help the reader understand whether the review concerns a current question, and whether it is up to date. It is a pilot project by the Cochrane Infectious Diseases Group editors to help readers and we welcome feedback. It has three components:

1. Whether the review is currently relevant. For this, we classify reviews into:

  • Historical question, where the intervention or policy has been superseded by new medical developments (such as a new drug);

  • Current question, which is still relevant to current policy or practice.

2. Whether the review is up to date: for this, we classify reviews into:

  • Up to date;

  • Update pending; or

  • No update intended.

3. An explanation of the review status.

This narrative text provides a little more additional information to explain the categories selected.

The editorial group responsible for this previously published document have withdrawn it from publication.

What's new

Last assessed as up-to-date: 31 July 2008.

DateEventDescription
2 September 2011Amended

Azithromycin treatments are included in another Cochrane review: Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). This latter review is in the process of being updated, and this review on azithromycin is therefore withdrawn.

The CIDG is piloting a new classification system for reviews. The classification for this has now been added; description included in "Published notes" section of review

Sources of support

Internal sources

  • University of Calabar Teaching Hospital, Nigeria.

  • Effective Health Care Alliance Programme (EHCAP), Nigeria.

External sources

  • Reviews for Africa Programme Fellowship, South Africa.

  • Department for International Development (DFID), UK.